MSB 7.69% $1.19 mesoblast limited

Ann: Remestemcel-L for COVID-19 MIS-C published in Pediatrics, page-169

  1. 2,714 Posts.
    lightbulb Created with Sketch. 1805
    Great to see #MSC therapy continue to demonstrate its efficacy not only against #covidー19, but now against #MIS in #children. Looking forward to seeing the results from a larger clinical cohort. #sars2#sars_cov_2#C#covid19researchOVID

    There you go Doc Mc- I googled a world wide expert , I copied his tweet from 8 hours ago. Now I’ve pasted it for you to read.

    Someone needs to tell this bloke to stop saying Msc therapy is effective against Covid-19. He’s on the global Covid-19 taskforce, must be a deluded soul. Then he has the audacity to say it’s demonstrating efficacy in kids with Mis-c, drag him out and stone him. What witchcraft is this?

    Seriously I could turn for young Yan ,

    am I allowed to say that these days?

    Reg

    Come on Ards results !!!!!
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.